| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/12/2006 | EP1345920B1 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/12/2006 | EP1334174B1 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 04/12/2006 | EP1331940B1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 04/12/2006 | EP1317272B1 Composition for improving the cell protection comprising a lipophilic antioxidant an a hydrophilic antioxidant |
| 04/12/2006 | EP1299089B1 Drug delivery system for poorly water soluble drugs |
| 04/12/2006 | EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 04/12/2006 | EP1207873A4 Methods of inhibiting osteoclast activity |
| 04/12/2006 | EP1192247B1 Sphingosine kinase enzyme |
| 04/12/2006 | EP1144435B1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2006 | EP1140175B1 Antibodies to truncated vegf-d and uses thereof |
| 04/12/2006 | EP1100821B1 Anti-inflammatory compounds derived from lipocortin-1 |
| 04/12/2006 | EP1054887B1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 04/12/2006 | EP1032555B1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 04/12/2006 | EP1009387B1 Stabilized sustained release tramadol formulations |
| 04/12/2006 | EP0985046B1 Recombinant poxvirus incapable of expressing a41l gene, coding for a soluble protein that binds chemokines |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN1759114A Heterocyclic N-aryl carboxamides as cytokine inhibitors |
| 04/12/2006 | CN1759103A Water-soluble phenylpyridazine derivative and medicine containing the same |
| 04/12/2006 | CN1250717C Human Enzymes of metalloprotease family |
| 04/12/2006 | CN1250570C Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 04/12/2006 | CN1250551C Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/12/2006 | CN1250526C Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 04/12/2006 | CN1250295C Magnetism and drug combined type fragrant baldric for avoiding plague |
| 04/12/2006 | CN1250281C Method for treating endothelium wound |
| 04/12/2006 | CN1250280C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 04/12/2006 | CN1250277C Medicine with anti-inflammatory, analgetic, bacteriostatic and diuretic effects |
| 04/12/2006 | CN1250270C Medicinal wine for expelling wind, eliminating dampness, relaxing tendon and stopping pain |
| 04/12/2006 | CN1250268C Fumigant |
| 04/12/2006 | CN1250248C Analgesic |
| 04/12/2006 | CN1250239C Medicine for treating backache and its prepn. method |
| 04/12/2006 | CN1250223C Pyrrolo-triazine and pyrimidine compounds |
| 04/12/2006 | CN1250211C Therapeutic and preventives agent containing cyclopentenone compounds as the active ingredient |
| 04/12/2006 | CN1250115C Use of lignan in foods |
| 04/11/2006 | US7026510 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents |
| 04/11/2006 | US7026501 Inhibitors of α4 mediated cell adhesion |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026487 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026462 Regulation of angiogenesis with zinc finger proteins |
| 04/11/2006 | US7026352 Physiologically active substances |
| 04/11/2006 | US7026349 Sulfonamides |
| 04/11/2006 | US7026348 Antiinflammatory agents; sepsis shock; rheumatic diseases |
| 04/11/2006 | US7026335 Melanocortin receptor ligands |
| 04/11/2006 | US7026331 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 04/11/2006 | US7026328 Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins |
| 04/11/2006 | US7026327 2-etherified 4-fluoroalkyl-6-(p-sulfonylphenyl)pyrimidines,e.g., 2-(4-fluorophenoxy)-4-[4-(methylsulfonyl)phenyl]-6](trifluoromethyl)pyrimidine; treatment of the pain, fever and inflammation of variety of conditions and diseases |
| 04/11/2006 | US7026326 Substituted heterocyclic compounds and methods of use |
| 04/11/2006 | US7026319 Use of vitamin combination for the treatment of pruritus and non-infective disorders involving itching and/or inflammation |
| 04/11/2006 | US7026316 (optionally aza)cycloalkyl-N,N-optionally thia-, oxothia- or dioxothia-)alkyleneglycine derivatives, e.g., N-{4-[(1S)-1-amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl}-N'-hexylureA; especially treating type 2 diabetes |
| 04/11/2006 | US7026311 Dibenzodiazepine derivatives, their preparation and use |
| 04/11/2006 | US7026309 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 04/11/2006 | US7026284 Formative agent of protein complex |
| 04/11/2006 | US7025983 Water soluble film forming polymer |
| 04/11/2006 | CA2411008C Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 04/06/2006 | WO2006036527A1 Substituted dipiperdine ccr2 antagonists |
| 04/06/2006 | WO2006036512A2 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 04/06/2006 | WO2006036507A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | WO2006036497A2 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | WO2006036480A1 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists |
| 04/06/2006 | WO2006036031A1 Fused furan derivative and use thereof |
| 04/06/2006 | WO2006035876A1 Preventive and/or therapeutic medicine for rheumatoid arthritis |
| 04/06/2006 | WO2006035760A1 Drug for treating skin disease |
| 04/06/2006 | WO2006035759A1 Drug for treating respiratory disease |
| 04/06/2006 | WO2005120158A3 Herbal compositions for prevention and treatment of rheumatic and inflammatory diseases and method of preparing the same |
| 04/06/2006 | US20060074244 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | US20060074106 Treatment of inflammatory disorders |
| 04/06/2006 | US20060074096 anti-cell prolifertive agents; 4-(1,2-diethylimidazol-5-yl)-2-{4-[N-(2-ethoxyethyl)sulphamoyl]anilino}pyrimidine; cancers, solid tumours, leukemias, psoriasis, rheumatoid arthritis, Kaposi's sarcoma, hemangioma, nephropathies, atheroma, atherosclerosis, restenosis, autoimmune diseases, inflammation |
| 04/06/2006 | US20060074092 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin K inhibitory activity for the treatment of inflammations and other diseases |
| 04/06/2006 | US20060074090 1,2,5-Thiadiazol-3-yl-piperazine therapeutic agents useful for treating pain, depression and anxiety |
| 04/06/2006 | US20060074069 e.g. (2R-trans) [4-(4-azetidin-3-yl-piperazin-1-yl)-2-benzyl-piperidin-1-yl]-(3,5-bis-trifluoromethyl-phenyl)-methanone;tachykinins, substance P inhibitor; antidepressant, anxiolytic, antiinflammatory agent, cognition activator; neurodegenerative diseases; addiction, sleep, eating disorders |
| 04/06/2006 | US20060074062 Substituted porphyrins |
| 04/06/2006 | US20060073333 Dispersing a matrix of nanostructured liquid phase or a dehydrated variant and a nanostructured liquid crystalline phase or a dehydrated variant in nonlamellar material; cooling or evaporating a volatile solvent |
| 04/06/2006 | US20060073186 Nutritional compositions |
| 04/06/2006 | US20060073162 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 04/06/2006 | US20060073146 Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| 04/06/2006 | US20060073115 Autoimmune diseases, graft rejections, chronic inflammations, sepsis, ischemia and reperfusion syndrome and atherosclerosis, inflamamatory disorders or infection by microorganisms |
| 04/06/2006 | US20060073100 Detection and therapy of vulnerable plaque with fluorescent and/or radiolabeled compositions |
| 04/06/2006 | DE10231370B4 Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel Thiophenglycosidderivate, pharmaceutical compositions containing them and methods for making these drugs |
| 04/06/2006 | CA2583464A1 Ecteinascidin compounds as anti -inflammatory agents |
| 04/06/2006 | CA2582225A1 Substituted dipiperdine ccr2 antagonists |
| 04/06/2006 | CA2582071A1 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 04/06/2006 | CA2581828A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | CA2581823A1 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | CA2581579A1 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists |
| 04/05/2006 | EP1642975A2 Chemokine receptors 88-2B (CKR-3) and their antibodies |
| 04/05/2006 | EP1642974A1 Recombinant soluble Fc receptors |
| 04/05/2006 | EP1642973A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642972A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642888A1 compounds for modulating the rage receptor |
| 04/05/2006 | EP1642885A1 Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for treating inflammatory conditions of the gastrointestinal tract |
| 04/05/2006 | EP1642596A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/05/2006 | EP1642593A1 Solid pharmaceutical preparation |
| 04/05/2006 | EP1642591A1 MEDICINAL COMPOSITION CONTAINING NF-kAPPA B DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME |
| 04/05/2006 | EP1642587A1 Follicle-stimulating hormone releasing agent |
| 04/05/2006 | EP1642578A2 Fentanyl composition for nasal administration |
| 04/05/2006 | EP1642574A2 Combination of a beta-2 adrenoceptor agonist and an aminosugar and their use for the treatment of immunomodulatory disorders |
| 04/05/2006 | EP1642573A1 Use of GABA B receptor modulators for treating gastro-intestinal disorders |
| 04/05/2006 | EP1642135A1 Method for diagnosing inflammatory bowel disease |
| 04/05/2006 | EP1641804A1 Thienopyridone derivatives as kinase inhibitors |